bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report)’s share price hit a new 52-week high during trading on Monday . The company traded as high as $126.64 and last traded at $126.64, with a volume of 204 shares. The stock had previously closed at $120.85.
bioMérieux Stock Up 4.8 %
The stock has a 50 day moving average of $115.49 and a 200-day moving average of $112.78. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.20 and a current ratio of 2.21.
bioMérieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Featured Articles
- Five stocks we like better than bioMérieux
- What is a Bond Market Holiday? How to Invest and Trade
- How to Protect Your Portfolio When Inflation Is Rising
- Find and Profitably Trade Stocks at 52-Week Lows
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Short a Stock in 5 Easy Steps
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
